These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 645452)

  • 1. Comparative evaluation of peripheral effects of vincamine and serotonin in various in vitro and in vivo preparations.
    Garcha GS; Nistico G; Rotiroti D; Gizzo G
    Acta Neurol (Napoli); 1978; 33(1):63-78. PubMed ID: 645452
    [No Abstract]   [Full Text] [Related]  

  • 2. General pharmacological properties of the new vasodilator flosequinan.
    Ikezono K; Fujita S; Umezato M; Hosoki E; Toba Y; Kusunoki A; Shintani S
    Arzneimittelforschung; 1992 Oct; 42(10):1200-11. PubMed ID: 1472141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of serotonin and histamine on contractility of the smooth muscle of the digestive tract in experimental animals.
    Kedzierska L
    Arch Immunol Ther Exp (Warsz); 1970; 18(2):239-57. PubMed ID: 5420945
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on the vincamine-papaverine association. IV. Interference with beta-receptors in experimental animals.
    Cattani L; Costrini R; Manani G; Galzigna L; Giron GP; Costa G; Civran E; Bossi M
    Agressologie; 1978; 19(6):385-91. PubMed ID: 35999
    [No Abstract]   [Full Text] [Related]  

  • 5. General pharmacological profile of the new cognition-enhancing agent nefiracetam.
    Kitano Y; Makino M; Usui C; Takasuna K; Kasai Y; Hirohashi M; Tamura K; Takayama S; Kojima H; Iizuka H
    Arzneimittelforschung; 1994 Feb; 44(2A):199-210. PubMed ID: 8018090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. General pharmacology of the novel angiotensin converting enzyme inhibitor alacepril. 1st communication: Effects on cardiovascular, visceral and renal functions and on blood.
    Matsuno Y; Taira N; Fujitani B; Ito T; Kadokawa T
    Arzneimittelforschung; 1986; 36(1):55-62. PubMed ID: 3513777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. General pharmacological properties of the human corticotropin-releasing hormone corticorelin (human).
    Andoh K; Kimura T; Saeki I; Tabata R; Yamazaki S; Eguchi I; Hanazuka M; Horii D; Munt PL; Davis AS
    Arzneimittelforschung; 1994 Jun; 44(6):715-26. PubMed ID: 8053970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of vincamine on the fibrocellular smooth muscle].
    Spina G; Quarenghi F; Molinari R; Lavagnini A
    Farmaco Prat; 1977 Jul; 31(7):363-71. PubMed ID: 891899
    [No Abstract]   [Full Text] [Related]  

  • 9. General pharmacology of KB-944, a new calcium antagonist.
    Morita T; Fukuda T; Sukamoto T; Tajima S; Sato I; Ikeda Y; Kanazawa T; Hamada Y; Morimoto Y; Kitamura H; Kawakami K; Ito K; Nose T
    Arzneimittelforschung; 1982; 32(9):1060-8. PubMed ID: 6890827
    [No Abstract]   [Full Text] [Related]  

  • 10. [Respiratory effects of vincamine hydrochloride].
    Piacenza G; Pesce E; Marchini F
    Farmaco Prat; 1978 Jul; 33(7):319-25. PubMed ID: 744232
    [No Abstract]   [Full Text] [Related]  

  • 11. General pharmacological properties of the main metabolite of flosequinan.
    Fujita S; Ikezono K; Umezato M; Hosoki E; Toba Y; Ishikawa M; Kusunoki A; Shintani S
    Arzneimittelforschung; 1992 Oct; 42(10):1212-22. PubMed ID: 1335257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of vincamine, vinervine and serotonin on the sexual cycle in rats].
    Kurmukov AG; Akhmedkhodzhaeva KhS
    Farmakol Toksikol; 1976; 39(6):699-702. PubMed ID: 1035859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [General pharmacology of BMY-28100].
    Goto A; Amano M; Sakai A; Hara M; Takahashi N
    Jpn J Antibiot; 1990 Jul; 43(7):1289-309. PubMed ID: 2232158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [General pharmacology of a new substance derived from cinnamoyl piperazine. II. Action on general circulation and the autonomic nervous system. Other pharmacological properties].
    Pourrias B; Dorme N; Bouvet P; Raynaud G
    Therapie; 1971; 26(4):859-72. PubMed ID: 5119135
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of L-eburnamonine on bronchial respiratory resistance in the anesthetized guinea pig. Comparison with vincamine].
    Linée P; Lacroix P; Laville MP; Le Pollès JB
    C R Seances Soc Biol Fil; 1978; 172(6):1208-13. PubMed ID: 159107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cardiac effects of vincamine].
    Strubelt O; Iven H; Siegers CP; Schütt A
    Arzneimittelforschung; 1977; 27(6a):1264-70. PubMed ID: 578450
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pharmacodynamic studies with total alkaloids of Uvariopsis guineensis kay Annonacea].
    Quevauviller A; Bourrinet P; Bezançon M
    Therapie; 1977; 32(2):215-8. PubMed ID: 898129
    [No Abstract]   [Full Text] [Related]  

  • 18. General pharmacological profile of the new anti-ulcer drug 3-[[[2-(3,4-dimethoxyphenyl)ethyl]carbamoyl]methyl]-amino-N -methylbenzamide.
    Hirohashi M; Takasuna K; Kasai Y; Usui C; Tamura K; Kojima H
    Arzneimittelforschung; 1993 May; 43(5):569-77. PubMed ID: 8329002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. General pharmacology of beraprost sodium. 2nd communication: effect on the autonomic, cardiovascular and gastrointestinal systems, and other effects.
    Murata T; Murai T; Kanai T; Ogaki Y; Sanai K; Kanda H; Sato S; Kajikawa N; Umetsu T; Matsuura H
    Arzneimittelforschung; 1989 Aug; 39(8):867-76. PubMed ID: 2510743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. General pharmacological studies on N-(2,6-dimethylphenyl)-8-pyrrolizidineacetamide hydrochloride hemihydrate. 2nd communication: effect on the peripheral nervous system and peripheral organs.
    Hirotsu I; Kihara T; Hattori Y; Hatta M; Hirose N; Ishihara T; Satoh F
    Arzneimittelforschung; 1988 Oct; 38(10):1410-7. PubMed ID: 3196381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.